HealthEquity Stock Gains as Q2 Earnings Beat Estimates, Revenues Up Y/Y

HealthEquity (HQY) reported strong second-quarter fiscal 2026 results, with adjusted EPS of $1.08 and revenues of $325.8 million, both surpassing analyst estimates and showing significant year-over-year growth of 25.6% and 8.6% respectively. The company saw robust growth in total HSA assets, which reached $33.1 billion (up 12% Y/Y), and expanded gross and operating margins, leading to a 3.7% after-market share gain. Consequently, HQY raised its full-year fiscal 2026 revenue and EPS guidance, despite management acknowledging that broader labor market pressures are currently limiting the pace of new HSA account openings.

Analysis

HealthEquity, Inc. (HQY) delivered a robust second-quarter fiscal 2026 performance, significantly surpassing consensus estimates and demonstrating strong operational leverage. The company reported a 25.6% year-over-year increase in adjusted EPS to $1.08 and an 8.6% rise in revenue to $325.8 million, triggering a 3.7% after-market stock gain. Growth was underpinned by a 12% Y/Y expansion in total HSA assets to $33.1 billion, with custodial revenues proving to be the primary driver, increasing 15.3%. A key highlight was the substantial margin expansion; the operating margin widened by 790 basis points to 27.5%, fueled by revenue growth outpacing a 1.5% decline in total operating expenses. This strong profitability prompted management to raise its full-year fiscal 2026 guidance for both revenue and adjusted EPS. However, this positive operational narrative is tempered by management's caution regarding the broader labor market, where slowing job growth is muting the pace of new HSA account openings, a critical long-term growth metric.

Key Decisions for Investors

• Investors should view the strong Q2 results and raised full-year guidance as validation of the company's ability to drive profitability through operational leverage, supporting a constructive outlook on the stock.
• The primary forward-looking risk is the macroeconomic pressure on new account growth, so it is critical to monitor labor market data and the company's next report on new HSA additions to gauge the sustainability of its top-line expansion.
• Given the significant bottom-line beat and raised EPS guidance, investors may find the stock's valuation more compelling, but should weigh the strong current profitability against the external headwinds impacting customer acquisition when adjusting their positions.